Cd3 Cd14 Cd16 Antibodies
Cd3 Cd14 Cd16 Antibodies - Related Videos
06:28
A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
0 Views •
Cited by 13 •
2016
Monocytes are integral components of the human innate immune system that rely on glycolytic metabolism when activated. We describe a flow cytometry protocol to measure glucose transporter expression and glucose uptake by total monocytes and monocyte subpopulations in fresh whole blood.
13:21
Antibody Generation: Producing Monoclonal Antibodies Using Hybridomas
0 Views •
2023
Source: Frances V. Sjaastad1,2, Whitney Swanson2,3, and Thomas S. Griffith1,2,3,4 1 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Department of Urology, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Polyclonal antibodies are defined as a collection of antibodies directed against...
11:52
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
0 Views •
Cited by 6 •
2023
Osteoclasts are key bone-resorbing cells in the body. This protocol describes a reliable method for the in vitro differentiation of osteoclasts from human peripheral blood monocytes. This method can be used as an important tool to further understand osteoclast biology in homeostasis and in diseases.
04:57
A Flow Cytometry Assay to Identify Immune Cell Subsets in Peripheral Blood Mononuclear Cells
0 Views •
2025
This video demonstrates a flow cytometry-based technique using two fluorochromes to identify CD4+ and CD8+ T cells, γδ T cells, B cells, natural killer (NK) cells, and monocytes in human peripheral blood mononuclear cells (PBMCs). Upon incubating the cells with fluorochrome-conjugated antibodies against the surface markers, the cell subsets are identified using an optimal flow cytometric gating strategy.
01:10
Antibody Structure
0 Views •
2019
Overview Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding. The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains Antibodies consist of four polypeptide chains: two identical heavy...
FAQs
CD3 antibody signal helps distinguish T-cell representation within the leukocyte compartment because CD3 recognizes the T-cell receptor complex. In cancer samples, measuring CD3-positive cells provides a readout of T-cell presence that can be compared with CD14- and CD16-associated populations. This supports analysis of how immune composition differs among tumors or experimental conditions.
CD14 and CD16 should not be treated as interchangeable myeloid markers. CD14 labels monocytes and related myeloid cells, whereas CD16 detects FcγRIII on natural killer cells and subsets of monocytes. Their different expression patterns help distinguish immune populations that might otherwise be grouped together, improving characterization of leukocyte composition in tumor-associated samples.
Using the three antibodies together provides complementary information about T cells, monocytes and related myeloid cells, and natural killer cells or CD16-positive monocyte subsets. This combined view helps researchers compare the relative representation of major immune populations rather than evaluating one lineage in isolation. The resulting profile can clarify changes in tumor-associated immune composition.
The assay format determines the type of information obtained. Flow cytometry supports characterization of labeled leukocyte populations, immunohistochemistry enables examination of marker-positive cells in tissue, and cell-isolation workflows use antibody-defined populations for further study. Selecting among these approaches allows researchers to emphasize cellular composition, tissue-associated immune patterns, or access to selected cells.
A basic workflow begins by selecting the antibody combination that matches the immune populations under investigation, followed by applying the reagents in an appropriate flow cytometry, immunohistochemistry, or cell-isolation procedure. Researchers then examine the resulting marker-defined populations and compare immune composition between samples. The workflow should reflect whether the study requires profiling, tissue assessment, or cell recovery.
Researchers can use the marker patterns to characterize leukocytes present within tumor samples and determine how T-cell, monocyte-related, natural-killer-cell, and CD16-positive monocyte populations are represented. Comparing these profiles across tumors or study groups can reveal shifts in immune composition. Such measurements help investigate interactions between immune cells and cancer within the tumor environment.
Marker-based immune profiling can provide measurements of cellular composition that support biomarker development and evaluation of immunotherapy responses. Changes in the representation of CD3-, CD14-, or CD16-associated populations may be examined across cancer samples or treatment-related comparisons. These data help researchers assess whether immune composition is associated with tumor biology or response-related patterns.